DK1028110T3 - Hidtil ukendte dihydronaphthalenforbindelser og fremgangsmåde til fremstilling deraf - Google Patents

Hidtil ukendte dihydronaphthalenforbindelser og fremgangsmåde til fremstilling deraf

Info

Publication number
DK1028110T3
DK1028110T3 DK98945556T DK98945556T DK1028110T3 DK 1028110 T3 DK1028110 T3 DK 1028110T3 DK 98945556 T DK98945556 T DK 98945556T DK 98945556 T DK98945556 T DK 98945556T DK 1028110 T3 DK1028110 T3 DK 1028110T3
Authority
DK
Denmark
Prior art keywords
inhibiting activity
cancer
preparation
new
methods
Prior art date
Application number
DK98945556T
Other languages
English (en)
Inventor
Rolf Wolfgang Hartmann
Bertil Wachall
Makoto Yoshihama
Masamichi Nakakoshi
Shin Nomoto
Yoshikazu Ikeda
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of DK1028110T3 publication Critical patent/DK1028110T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DK98945556T 1997-10-02 1998-10-01 Hidtil ukendte dihydronaphthalenforbindelser og fremgangsmåde til fremstilling deraf DK1028110T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28426397 1997-10-02
PCT/JP1998/004426 WO1999018075A1 (en) 1997-10-02 1998-10-01 Novel dihydronaphthalene compounds and process for producing the same

Publications (1)

Publication Number Publication Date
DK1028110T3 true DK1028110T3 (da) 2004-07-19

Family

ID=17676271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98945556T DK1028110T3 (da) 1997-10-02 1998-10-01 Hidtil ukendte dihydronaphthalenforbindelser og fremgangsmåde til fremstilling deraf

Country Status (17)

Country Link
EP (1) EP1028110B1 (da)
KR (1) KR20000069426A (da)
CN (1) CN1117732C (da)
AT (1) ATE264304T1 (da)
AU (1) AU743405B2 (da)
CA (1) CA2298527A1 (da)
DE (1) DE69823222T2 (da)
DK (1) DK1028110T3 (da)
ES (1) ES2218853T3 (da)
FI (1) FI20000207L (da)
HU (1) HUP0004037A3 (da)
IL (1) IL133483A0 (da)
NO (1) NO315044B1 (da)
NZ (1) NZ501822A (da)
RU (1) RU2203890C2 (da)
WO (1) WO1999018075A1 (da)
ZA (1) ZA988954B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100287366B1 (ko) 1997-11-24 2001-04-16 윤순조 엠피이지 방식을 이용한 휴대용 음향 재생장치 및 방법
US7001926B2 (en) 2000-03-10 2006-02-21 Oxigene, Inc. Tubulin binding agents and corresponding prodrug constructs
TWI283669B (en) * 1999-06-10 2007-07-11 Allergan Inc Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors
US6849656B1 (en) 1999-09-17 2005-02-01 Baylor University Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
JP4616454B2 (ja) * 1999-10-22 2011-01-19 武田薬品工業株式会社 1−置換フェニル−1−(1h−イミダゾール−4−イル)アルコール類、その製造法および用途
US6518257B1 (en) 1999-10-22 2003-02-11 Takeda Chemical Industries, Ltd. 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof
JP4520012B2 (ja) * 1999-10-22 2010-08-04 武田薬品工業株式会社 1−置換−1−(1h−イミダゾール−4−イル)メタノール類
AU4352701A (en) 2000-03-10 2001-09-24 Univ Baylor Tubulin binding ligands and corresponding prodrug constructs
US7091240B2 (en) 2000-03-10 2006-08-15 Oxigene, Inc. Tubulin binding ligands and corresponding prodrug constructs
CA2429133C (en) 2000-11-17 2009-08-18 Takeda Chemical Industries, Ltd. Novel imidazole derivatives, production method thereof and use thereof
DE60144246D1 (de) 2000-11-20 2011-04-28 Takeda Pharmaceutical Imidazolderivate, verfahren zu deren herstellung und deren verwendung
WO2002046186A1 (en) 2000-12-08 2002-06-13 Takeda Chemical Industries, Ltd. Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
JP2006508174A (ja) * 2002-01-25 2006-03-09 ファルマシア・コーポレーション 炎症関連疾患を予防または治療するためのアルドステロンブロッカー療法
US7456214B2 (en) 2004-05-03 2008-11-25 Baylor University Chromene-containing compounds with anti-tubulin and vascular targeting activity
PE20121048A1 (es) 2009-06-26 2012-08-25 Novartis Ag Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17
KR101594660B1 (ko) 2010-08-04 2016-02-16 펠피큐어 파마슈티걸즈 아이엔씨 전립선 암종의 치료를 위한 병용 요법
EP2627648A1 (en) 2010-09-16 2013-08-21 Novartis AG 17aHYDROXYLASE/C17,20-LYASE INHIBITORS
MX359399B (es) 2011-04-28 2018-09-27 Novartis Ag Inhibidores de 17alfa-hidroxilasa/c17-20-liasa.
AU2014241816B9 (en) 2013-03-14 2019-02-14 Pellficure Pharmaceuticals Inc. Novel therapy for prostate carcinoma
WO2016040896A1 (en) 2014-09-12 2016-03-17 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
WO2018080933A1 (en) 2016-10-24 2018-05-03 Pellficure Pharmaceuticals Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5681566A (en) * 1979-12-05 1981-07-03 Yoshitomi Pharmaceut Ind Ltd Imidazole derivative
ZA825413B (en) * 1981-08-26 1983-06-29 Pfizer Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
US4540705A (en) * 1983-03-14 1985-09-10 Sterling Drug Inc. Antidepressant imidazolines and related compounds
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative
JPS61186348A (ja) * 1985-02-14 1986-08-20 Dai Ichi Seiyaku Co Ltd ナフタレン誘導体
US4661596A (en) * 1985-02-21 1987-04-28 American Home Products Corporation Quinolinyl (or pyridinyl) methoxy substituted naphthalene compounds as antiallergic agents
DE3508905A1 (de) * 1985-03-13 1986-09-18 Hoechst Ag, 6230 Frankfurt Neue imidazolylverbindungen und verfahren zu ihrer herstellung
WO1989003681A1 (en) * 1987-10-19 1989-05-05 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma
JPH06166674A (ja) * 1992-12-01 1994-06-14 Tokyo Tanabe Co Ltd テトラリン化合物
JP3338905B2 (ja) * 1993-05-13 2002-10-28 帝国臓器製薬株式会社 6位置換ステロイド誘導体
EP0721943A4 (en) * 1993-09-30 1996-09-04 Yamanouchi Pharma Co Ltd AZOL DERIVATIVES AND PHARMACEUTICAL PREPARATIONS
FR2787451B1 (fr) * 1998-12-18 2001-01-26 Adir Nouveaux composes imidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
ZA988954B (en) 1999-04-12
AU9281098A (en) 1999-04-27
EP1028110B1 (en) 2004-04-14
DE69823222T2 (de) 2005-04-14
FI20000207A7 (fi) 2000-02-01
ATE264304T1 (de) 2004-04-15
NO20001289D0 (no) 2000-03-10
CA2298527A1 (en) 1999-04-15
NO20001289L (no) 2000-03-10
ES2218853T3 (es) 2004-11-16
CN1117732C (zh) 2003-08-13
FI20000207L (fi) 2000-02-01
NO315044B1 (no) 2003-06-30
EP1028110A4 (en) 2001-05-23
WO1999018075A1 (en) 1999-04-15
CN1268120A (zh) 2000-09-27
IL133483A0 (en) 2001-04-30
DE69823222D1 (de) 2004-05-19
RU2203890C2 (ru) 2003-05-10
AU743405B2 (en) 2002-01-24
EP1028110A1 (en) 2000-08-16
NZ501822A (en) 2001-12-21
KR20000069426A (ko) 2000-11-25
HUP0004037A2 (hu) 2001-10-28
HUP0004037A3 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
NO20001289L (no) Nye dihydronaftalenforbindelser og fremgangsmõte for fremstilling av samme
YU596A (sh) Estrogen agonisti/antagonisti
ATE368466T1 (de) Androgensyntheseinhibitoren
PT920312E (pt) Derivados de adamantilo indutores de apoptose e sua utilizacao como agentes anticancerigenos
NO952351L (no) 7-halo- og 7 e, og farmasöytiske preparater inneholdende disse
CY1107721T1 (el) Παραγωγα τυροζινης
DE69935335D1 (de) Pyrazole als modulatoren des östrogenrezeptors
PT971585E (pt) Compostos tetraciclina no tratamento de certos tipos de cancros
BG104315A (en) Prostaglandine agonists and their application for the treatment of osteal diseases
BR0112857A (pt) Compostos 2-(4-piridil)amino-6-dialcoxifenil-pirido-[2,3-d]pirimidin- 7-onas
TR199900239T2 (da)
DE69905476D1 (en) Phosphonsaürederivate als ptp-1b-inhibitoren
ATE243692T1 (de) Arylaminderivate und ihre verwendung als antitelomerasemittel
MXPA01008347A (es) Compuestos quimicos.
GB9817573D0 (en) Pharmaceutical compositions
ATE352567T1 (de) Herstellung von agonisten und antagonisten von cholecystokinin und ihre therapeutische und diagnostische verwendung
TR200002932T2 (tr) Azabisayklik 5HT1 Alıcı liganolları
IL126328A0 (en) 7 alpha-(5-Methylaminopentyl)-estratrienes pharmaceutical preparations containing the same and use thereof
BG106008A (en) Novel lhrh antagonists with improved solubility characteristics
TR199902971T2 (xx) Selim prostat hiperplazisinin tedavisinde yararl� aril ikameli piperazinler.
SE9604582D0 (sv) Novel compounds
PT880540E (pt) 17-beta-ciclopropil-(amino/oxi)-4-azaesteroides como inibidores activos de 5-alfa-redutase e c17-c20-liase de testosterona
DE69724548D1 (de) Substituierte 2,3-Aryl-Benzothiophene und ihre östrogene Aktivität
DE60214004D1 (en) Tricyclische epoxide
SE9603726D0 (sv) Novel compounds